Semaglutide, the active compound in popular weight loss medications, activates GLP-1 receptors throughout your bodyincluding in muscle tissuewhich can trigger cramping in some patients
Many people don't realize that not all GLP-1 products are made under the same standards and oversight
This study evaluated the pharmacokinetics and tolerability of tirzepatide in participants with hepatic impairment (with or without type 2 diabetes) versus healthy participants with normal hepatic function
This article is part of the Topical Collection on Other Forms of Diabetes and Its Complications Rights and permissions About this article Cite this article Jalleh, R., Marathe, C.S., Rayner, C.K
Tirzepatide, on the other hand, is a glucose-dependent insulinotropic polypeptide (GIP) receptor and GLP-1 receptor agonistsometimes called a dual GIP/GLP-1 receptor agonist